In the 4.5 years since our initial award, we have established CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV) as a National Center of Excellence for health economic research related to substance use disorder policy and HCV and HIV care of people who use substances. Our unique multi-institutional center leverages outstanding researchers with synergistic areas of expertise. In the initial award period, our aims have focused on addressing the needs of integrated healthcare system payers and providers. CHERISH guidance and input has resulted in addition of critical economic components to comparative effectiveness studies that evaluate treatments delivered to individual participants in healthcare or SUD treatment settings, including those evaluating interventions delivered at the health- system or organization level. In this renewal period, we propose to expand our focus to add economic components, develop economic methodologies, and improve knowledge translation strategies for health outcome and implementation research that is conducted at the individual, system, and community levels. Our proposal, entitled: ?Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities,? has the overall aim to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and HIV care of people who use substances. The Center includes 3 Research Support Cores (Methodology Core, Population Data & Modeling Core, and Dissemination & Policy Core), a Pilot Grant & Training Core that serves as the Pilot Research Project Core, and an Administrative Core. The Methodology Core will continue its highly successful Consultation Service and will develop new methods related to economic evaluation in implementation studies and adaptive interventions. The new Population Data & Modeling Core will draw on recent experience of Core members in Massachusetts to promote new approaches to state data linkages for population-level economic evaluations, and will support a research consortium that advances simulation modeling methods for these populations. The Dissemination & Policy Core will continue to engage in dissemination science activities that directly assist research teams and further the science, continue to hold bi-annual stakeholder conferences, and develop a new knowledge dissemination curriculum. The Pilot Grant & Training Core will continue to use experts from the other Cores and Research Affiliates to select, evaluate, and mentor competitive pilot grant awardees, will conduct new training and mentorship activities, and will lead a diversity initiative for the Center. The Administrative Core will continue to provide infrastructure and leadership to all Cores.
In the 4.5 years since our initial award, we have established CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV) as a National Center of Excellence for health economic research related to substance use disorder policy and HCV and HIV care of people who use substances. In this renewal period, we propose to expand our focus to add population data and modeling components, develop economic evaluation methodologies, and improve knowledge translation strategies for health outcomes and implementation research that is conducted at the individual, system, and community- levels. The Center includes 3 Scientific Cores (Methodology Core, Population Data & Modeling Core, and Dissemination & Policy Core) and 2 Supporting Cores (Pilot Grant & Training Core, Administrative Core).
|Assoumou, Sabrina A; Tasillo, Abriana; Leff, Jared A et al. (2018) Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis 66:376-384|
|Murphy, Sean M; McCollister, Kathryn E; Leff, Jared A et al. (2018) Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse. Ann Intern Med :|
|Miclette, Matthew A; Leff, Jared A; Cuan, Isabella et al. (2018) Closing the gaps in opioid use disorder research, policy and practice: conference proceedings. Addict Sci Clin Pract 13:22|
|Zhang, Yongkang; Johnson, Phyllis; Jeng, Philip J et al. (2018) First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults. J Gen Intern Med :|
|Behrends, Czarina N; Eggman, Ashley A; Gutkind, Sarah et al. (2018) A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination. J Public Health Manag Pract :|
|Delgado, M Kit; Huang, Yanlan; Meisel, Zachary et al. (2018) National Variation in Opioid Prescribing and Risk of Prolonged Use for Opioid-Naive Patients Treated in the Emergency Department for Ankle Sprains. Ann Emerg Med 72:389-400.e1|
|Linas, Benjamin P; Nolen, Shayla (2018) A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am 32:447-459|
|Epstein, Rachel L; Sabharwal, Vishakha; Wachman, Elisha M et al. (2018) Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr 203:34-40.e1|
|Murphy, Sean M; Leff, Jared A; Linas, Benjamin P et al. (2018) Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned. Subst Abus :1-19|
|Bao, Yuhua; Wen, Katherine; Johnson, Phyllis et al. (2018) Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions. Health Aff (Millwood) 37:1596-1604|
Showing the most recent 10 out of 93 publications